Sonoma Pharmaceuticals (SNOA) Notes Payables (2011 - 2026)
Sonoma Pharmaceuticals (SNOA) posted quarterly Notes Payables of $222000.0 for Q1 2026, up 0.91% year-over-year from $220000.0 in Q1 2025, and up 296.43% quarter-over-quarter from $56000.0 in Q3 2025.
Sonoma Pharmaceuticals (SNOA) Notes Payables (2011 - 2026) Analysis & Trends
Sonoma Pharmaceuticals' Notes Payables history runs 9 years deep, the most recent figure standing at $222000.0 for Q1 2026.
- In Q1 2026, Notes Payables rose 0.91% year-over-year to $222000.0; the TTM figure through Mar 2026 stood at $222000.0 (up 0.91% YoY), while the FY2026 annual figure was $222000.0, up 0.91% from the prior year.
- Notes Payables for Q1 2026 stood at $222000.0, up from $56000.0 in the prior quarter.
- The five-year high for Notes Payables was $431000.0 in Q1 2023, with the low at $56000.0 in Q3 2025.
- The 5-year median for Notes Payables is $204000.0 (2024), against an average of $199666.7.
- The sharpest annual moves came in 2023 and 2025: Notes Payables surged 259.17% in 2023, then plunged 31.89% in 2025.
- Sonoma Pharmaceuticals' Notes Payables stood at $120000.0 in 2022, then soared by 259.17% to $431000.0 in 2023, then plunged by 80.97% to $82000.0 in 2024, then tumbled by 31.71% to $56000.0 in 2025, then jumped by 296.43% to $222000.0 in 2026.
- Business Quant data shows SNOA's Notes Payables at $222000.0 in Q1 2026, $56000.0 in Q3 2025, and $139000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Sonoma Pharmaceuticals | 5.17 Mn | -165,129.89 | 2.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 140,000.00 |
| Mar 31, 2026 | 222,000.00 |
| Sep 30, 2025 | 56,000.00 |
| Jun 30, 2025 | 139,000.00 |
| Mar 31, 2025 | 220,000.00 |
| Sep 30, 2024 | 82,000.00 |
| Jun 30, 2024 | 204,000.00 |
| Mar 31, 2024 | 323,000.00 |
| Mar 31, 2023 | 431,000.00 |
| Mar 31, 2022 | 120,000.00 |
| Dec 31, 2015 | 1,000.00 |
| Sep 30, 2015 | 5,000.00 |
| Jun 30, 2015 | 70,000.00 |
| Mar 31, 2015 | 11,000.00 |
| Dec 31, 2014 | 177,000.00 |
| Sep 30, 2014 | 856,000.00 |
| Mar 31, 2014 | 3.18 Mn |
| Sep 30, 2012 | 1.55 Mn |
| Jun 30, 2012 | 1.16 Mn |
| Mar 31, 2012 | 55,000.00 |